Portage Biotech Inc.

5.80
-0.23 (-3.81%)
At close: Apr 04, 2025, 12:48 PM

Portage Biotech Statistics

Share Statistics

Portage Biotech has 1.12M shares outstanding. The number of shares has increased by -94.33% in one year.

Shares Outstanding 1.12M
Shares Change (YoY) -94.33%
Shares Change (QoQ) 0%
Owned by Institutions (%) 10.71%
Shares Floating 275.06K
Failed to Deliver (FTD) Shares 2.99K
FTD / Avg. Volume 0.49%

Short Selling Information

The latest short interest is 10.04K, so 0.9% of the outstanding shares have been sold short.

Short Interest 10.04K
Short % of Shares Out 0.9%
Short % of Float 1.36%
Short Ratio (days to cover) 0.17

Valuation Ratios

The PE ratio is -2.99 and the forward PE ratio is -9.04. Portage Biotech's PEG ratio is 0.07.

PE Ratio -2.99
Forward PE -9.04
PS Ratio 0
Forward PS 2.8
PB Ratio 55.93
P/FCF Ratio -15.74
PEG Ratio 0.07
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Portage Biotech.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.01.

Current Ratio 2.67
Quick Ratio 2.67
Debt / Equity 0.01
Debt / EBITDA 0
Debt / FCF 0
Interest Coverage -570.41

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-10.76M
Employee Count 7
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -10.55M
Effective Tax Rate 12.31%

Stock Price Statistics

The stock price has increased by -39.59% in the last 52 weeks. The beta is 0.97, so Portage Biotech's price volatility has been higher than the market average.

Beta 0.97
52-Week Price Change -39.59%
50-Day Moving Average 4.79
200-Day Moving Average 4.73
Relative Strength Index (RSI) 53.7
Average Volume (20 Days) 616.09K

Income Statement

Revenue n/a
Gross Profit -54K
Operating Income -18.25M
Net Income -75.34M
EBITDA -18.2M
EBIT -18.25M
Earnings Per Share (EPS) -3.7
Full Income Statement

Balance Sheet

The company has 5.03M in cash and 47K in debt, giving a net cash position of 4.98M.

Cash & Cash Equivalents 5.03M
Total Debt 47K
Net Cash 4.98M
Retained Earnings -239.32M
Total Assets 2.71M
Working Capital 1.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.3M and capital expenditures 0, giving a free cash flow of -14.3M.

Operating Cash Flow -14.3M
Capital Expenditures 0
Free Cash Flow -14.3M
FCF Per Share -0.7
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PRTG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for PRTG.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Aug 15, 2024. It was a backward split with a ratio of 1:20.

Last Split Date Aug 15, 2024
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score -216.7
Piotroski F-Score 3